Status:
UNKNOWN
Using of Collagen Matrix for Maxillary Tuberosity Donor Area Preservation
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University
Conditions:
Soft Tissue Atrophy
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
An interventional prospective randomised clinical trial (RCT) in parallel groups is planned. The sample size was 30 patients who will be randomly divided into two groups based on the surgical procedur...
Detailed Description
The aim of this study is to perform a comparative analysis of the effectiveness of using a double-layer collagen matrix to preserve the parameters of the donor area in the region of the maxillary tube...
Eligibility Criteria
Inclusion
- Presence of written informed consent of the patient to participate in the study;
- Age between 18 and 45 years;
- Included defects on the maxilla or mandible within 1-2 teeth combined with soft tissue thickness deficiency in the area of dental implants (\< 2 mm);
- Teeth without periodontal pathology, probing depth should not exceed 3 mm across the entire dentoalveolar sulcus;
- Satisfactory level of oral hygiene;
- Absence of general diseases in the stage of exacerbation or decompensation
- Non-inclusion criteria:
- Patients who had previous harvesting of CTG from the same donor area;
- Patients with impacted third molars in the donor area;
- Presence of concomitant diseases in the stage of exacerbation or decompensation;
- Patients with oncological diseases, as well as patients who have received radiotherapy and chemotherapy in the last 5 years;
- Patients with a history of smoking for more than 10 years.
Exclusion
- Patient refusal of further participation in the study;
- Pregnant and breastfeeding women;
- Patients with blood coagulation disorders (haemophilia, Willebrand's disease, intake of anticoagulants);
- Patients with diseases that impair soft tissue healing (insulin-dependent diabetes mellitus).
Key Trial Info
Start Date :
January 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06039839
Start Date
January 17 2023
End Date
May 15 2025
Last Update
September 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Moscow, Russia